A májzsírosodás és a hepatitis C-vírus-fertõzés
: Fatty liver and hepatitis C virus infection
Lakatos Marianna, K. Hagymási, G. Lengyel
Hepatitis C virus infection is a common liver disease worldwide, leading to the development of steatosis, cirrhosis and hepatocellular carcinoma. In patients with chronic hepatitis C virus infection the prevalence of steatosis has been estimated to be about 55%. Development of steatosis is due to both viral and metabolic factors. Hepatitis C virus proteins moderate a number of intracellular pathways, however, further studies are required to understand these mechanisms. Obesity and insulin resistance may allow the virus to resist antiviral treatment. This review discusses the relationship among steatosis, insulin resistance and the response to antiviral therapy.
https://doi.org/10.1556/OH.2011.29209
Chronic Hepatitis C
Marianna, L., Hagymási, K., & Lengyel, G. (2011). A májzsírosodás és a hepatitis C-vírus-fertõzés. Orvosi Hetilap, 152(38), 1513-1519. https://doi.org/10.1556/OH.2011.29209
A májzsírosodás és a hepatitis C-vírus-fertõzés. / Marianna, Lakatos; Hagymási, K.; Lengyel, G.
In: Orvosi Hetilap, Vol. 152, No. 38, 01.09.2011, p. 1513-1519.
Marianna, L, Hagymási, K & Lengyel, G 2011, 'A májzsírosodás és a hepatitis C-vírus-fertõzés', Orvosi Hetilap, vol. 152, no. 38, pp. 1513-1519. https://doi.org/10.1556/OH.2011.29209
Marianna L, Hagymási K, Lengyel G. A májzsírosodás és a hepatitis C-vírus-fertõzés. Orvosi Hetilap. 2011 Sep 1;152(38):1513-1519. https://doi.org/10.1556/OH.2011.29209
Marianna, Lakatos ; Hagymási, K. ; Lengyel, G. / A májzsírosodás és a hepatitis C-vírus-fertõzés. In: Orvosi Hetilap. 2011 ; Vol. 152, No. 38. pp. 1513-1519.
@article{4532e19560174fc0bcf862cbf063533e,
title = "A m{\'a}jzs{\'i}rosod{\'a}s {\'e}s a hepatitis C-v{\'i}rus-fert{\~o}z{\'e}s",
abstract = "Hepatitis C virus infection is a common liver disease worldwide, leading to the development of steatosis, cirrhosis and hepatocellular carcinoma. In patients with chronic hepatitis C virus infection the prevalence of steatosis has been estimated to be about 55{\%}. Development of steatosis is due to both viral and metabolic factors. Hepatitis C virus proteins moderate a number of intracellular pathways, however, further studies are required to understand these mechanisms. Obesity and insulin resistance may allow the virus to resist antiviral treatment. This review discusses the relationship among steatosis, insulin resistance and the response to antiviral therapy.",
keywords = "antiviral treatment, Hepatitis C virus, insulin resistance, steatosis",
author = "Lakatos Marianna and K. Hagym{\'a}si and G. Lengyel",
doi = "10.1556/OH.2011.29209",
T1 - A májzsírosodás és a hepatitis C-vírus-fertõzés
AU - Marianna, Lakatos
AU - Hagymási, K.
AU - Lengyel, G.
N2 - Hepatitis C virus infection is a common liver disease worldwide, leading to the development of steatosis, cirrhosis and hepatocellular carcinoma. In patients with chronic hepatitis C virus infection the prevalence of steatosis has been estimated to be about 55%. Development of steatosis is due to both viral and metabolic factors. Hepatitis C virus proteins moderate a number of intracellular pathways, however, further studies are required to understand these mechanisms. Obesity and insulin resistance may allow the virus to resist antiviral treatment. This review discusses the relationship among steatosis, insulin resistance and the response to antiviral therapy.
AB - Hepatitis C virus infection is a common liver disease worldwide, leading to the development of steatosis, cirrhosis and hepatocellular carcinoma. In patients with chronic hepatitis C virus infection the prevalence of steatosis has been estimated to be about 55%. Development of steatosis is due to both viral and metabolic factors. Hepatitis C virus proteins moderate a number of intracellular pathways, however, further studies are required to understand these mechanisms. Obesity and insulin resistance may allow the virus to resist antiviral treatment. This review discusses the relationship among steatosis, insulin resistance and the response to antiviral therapy.
KW - antiviral treatment
KW - Hepatitis C virus
KW - insulin resistance
KW - steatosis
U2 - 10.1556/OH.2011.29209
DO - 10.1556/OH.2011.29209
10.1556/OH.2011.29209